A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients

Table 1

Patients’ demographics.

	Patients ( = 110)	%
Median age
Years (range)	68 (53–89)
Sex
Male	93	84.5
Female	17	15.5
Histology
Adenocarcinoma	57	51.8
Squamous	37	33.6
Other types	16	14.6
Stage
IIIA/B (noneligible for radiation)	28	25.5
IV	82	74.5
Treatment regimens
Platinum-based	86	78.3
Taxane-based + bevacizumab	15	13.6
Taxane (single agent)	5	4.5
Taxane (single agnet) + bevacizumab	4	3.6
Response to therapy
PR	25	22.7
SD	39	35.5
PD	24	21.8
NE	22	20.0

NE: nonevaluated, PR: partial response, SD: stable disease, PD: progressive disease.